Nitazoxanide for cryptosporidial diarrhea.
Bowers
M
M
D017088:AIDS-Related Opportunistic Infections / Q000188:drug therapy*; D000981:Antiprotozoal Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002986:Clinical Trials as Topic; D003457:Cryptosporidiosis / Q000150:complications / Q000188:drug therapy*; D016785:Cryptosporidium parvum / Q000187:drug effects; D003967:Diarrhea / Q000188:drug therapy* / Q000469:parasitology; D004359:Drug Therapy, Combination; D006297:Health Services Accessibility; D006801:Humans; D009574:Nitro Compounds; D012307:Risk Factors; D013844:Thiazoles / Q000008:administration & dosage / Q000627:therapeutic use*
D000981:Antiprotozoal Agents; D009574:Nitro Compounds; D013844:Thiazoles; C041747:nitazoxanide